| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.47B | 48.58B | 44.26B | 43.32B | 41.88B | 41.20B |
| Gross Profit | 16.81B | 18.91B | 17.10B | 16.67B | 17.66B | 16.07B |
| EBITDA | 6.25B | 7.93B | 7.17B | 6.26B | 7.94B | 7.25B |
| Net Income | 2.08B | 3.18B | 2.48B | 2.22B | 3.25B | 3.12B |
Balance Sheet | ||||||
| Total Assets | 80.71B | 79.86B | 81.16B | 72.05B | 66.45B | 62.61B |
| Cash, Cash Equivalents and Short-Term Investments | 9.71B | 10.77B | 12.96B | 10.49B | 11.45B | 9.45B |
| Total Debt | 8.16B | 8.79B | 9.81B | 11.08B | 7.02B | 8.19B |
| Total Liabilities | 20.81B | 21.32B | 23.71B | 22.16B | 18.54B | 18.96B |
| Stockholders Equity | 49.51B | 48.60B | 47.73B | 42.83B | 41.41B | 38.67B |
Cash Flow | ||||||
| Free Cash Flow | -1.04B | 248.00M | 2.99B | -2.06B | 4.38B | 3.07B |
| Operating Cash Flow | 4.24B | 5.67B | 8.34B | 1.06B | 6.14B | 5.38B |
| Investing Cash Flow | -3.05B | -6.55B | -3.95B | -7.04B | -3.57B | -2.69B |
| Financing Cash Flow | -2.24B | -1.88B | -2.07B | 2.29B | -1.85B | -424.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥30.66B | 11.79 | ― | 1.96% | 2.15% | 16.14% | |
77 Outperform | ¥40.07B | 11.50 | ― | 2.75% | 5.16% | 32.19% | |
75 Outperform | ¥28.04B | 13.64 | ― | 3.07% | 5.29% | 1.50% | |
73 Outperform | ¥29.74B | 13.88 | ― | 2.67% | -6.65% | -45.46% | |
72 Outperform | ¥36.29B | 14.36 | ― | 2.41% | 0.81% | 2.21% | |
64 Neutral | ¥21.57B | 12.44 | ― | 4.44% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Hodogaya Chemical Co., Ltd. announced that its consolidated subsidiary, SFC CO., LTD., is preparing for an IPO on the Korea Exchange Securities Market (KOSPI). This move, pending approval from Korean authorities, could enhance SFC’s market positioning and potentially increase shareholder value, reflecting Hodogaya’s strategic expansion in the Asian market.
The most recent analyst rating on (JP:4112) stock is a Buy with a Yen1975.00 price target. To see the full list of analyst forecasts on Hodogaya Chemical Co., Ltd. stock, see the JP:4112 Stock Forecast page.
Hodogaya Chemical Co., Ltd. reported a significant decline in its financial performance for the three months ended June 30, 2025, with net sales and profits dropping sharply compared to the previous year. Despite these challenges, the company maintains a stable financial position with a slight increase in total assets and net assets. The company also announced a stock split and adjusted its dividend forecast accordingly.